ADVIA Centaur Insulin (IRI) Master Curve Material (MCM), ADVIA Centaur (IRI) Calibrator
Calibrator, Secondary. 510(k) K162538, from Siemens Healthcare Diagnostics (East Walpole, MA). Product code JIT, class 2.
As of Nov 18, 2026, K162538 is an FDA 510(k) held by Siemens Healthcare Diagnostics, substantially equivalent on Nov 17, 2016 after 66 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Nov 17, 2016
- Review time: 66 days
- Recalls: 0
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe ADVIA Centaur® Insulin (IRI) Master Curve Material (MCM) is for in vitro diagnostic use in the verification of calibration and reportable range of the ADVIA Centaur® Insuin assay. The ADVIA Centaur® Insulin (IRI) Calibrator is for in vitro diagnostic use in calibrating the ADVIA Centaur® systems Insulin assays.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- ADVIA Centaur C-peptide (CpS) Master Curve Material (MCM), ADVIA Centaur Insulin (IRI) Master Curve Material (MCM)K142864 · Siemens Healthcare Diagnostics, Inc. · Oct 29, 2014
- Advia Cantaur And ACS:180 Insulin CalibratorK021535 · Bayer Diagnostics Corp. · Jun 27, 2002
- Bayer Advia Centaur Automated Chemiluminescence AnalyzerK032525 · Bayer Healthcare, LLC · Sep 9, 2003
- Modification To Bayer Advia Centaur Automated Chemiluminescence AnalyzerK041133 · Bayer Healthcare, LLC · Jul 2, 2004
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Sep 12, 2016
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1150
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files